Perrigo Ordinary Shares reported $92.6M in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3735M 316M
Abbvie ABBV:US $ 7127M 482M
Bristol Myers Squibb BMY:US $ 5772M 404M
Catalent CTLT:US $ 315M 39M
Coherus Biosciences CHRS:US $ -80.12M 41.48M
Corcept Therapeutics CORT:US $ 27.06M 9.9M
Dr.Reddys Laboratories DRRD:IN IR 11929M 275M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Endo International Ordinary Shares ENDP:US $ 226.56M 52.35M
Horizon Pharma HZNP:US $ 291.56M 100.61M
JAZZ PHA JAZZ:US $ 267.26M 90.66M
Johnson & Johnson JNJ:US $ 9309M 1549M
Lannett LCI:US $ -12.48M 3.96M
Merk MRK:US $ 6179M 492M
Pacira Pharmaceuticals PCRX:US $ 41.76M 17.12M
Perrigo Ordinary Shares PRGO:US $ 92.6M 43.6M
Pfizer PFE:US $ 11182M 4046M
Phibro Animal Health PAHC:US $ 27.64M 2.66M
Prestige Brands PBH:US $ 85.91M 4.73M
Supernus Pharmaceuticals SUPN:US $ 23.33M 17.79M
Teva Pharmaceutical TEVA:IT 1.11B 176M
Xeris Pharmaceuticals Inc XERS:US $ -16042000 29.13M
Zoetis ZTS:US $ 908M 194M